Base excision repair sensitizes cells to sulfur mustard and chloroethyl ethyl sulfide

DNA Repair

Volumn 6, Issue 6, 2007, Pages 733-741

  Matijasevic, Zdenka ^a   Volkert, Michael R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Alkylation damage; Base excision repair; Hypothermia; Mutagenesis; Nucleotide excision repair; Sulfur mustard compounds

Indexed keywords

CHLOROETHYLETHYLSULFIDE; DNA GLYCOSYLTRANSFERASE; MUSTARD GAS; MUSTARD GAS DERIVATIVE; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CELL SURVIVAL; CHEMICAL STRUCTURE; CONTROLLED STUDY; CROSS LINKING; DNA ADDUCT; DNA DAMAGE; DNA DETERMINATION; DNA REPAIR; ENZYME MECHANISM; EXCISION REPAIR; HYPOTHERMIA; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIZATION;

ANIMALS; CELL SURVIVAL; DNA DAMAGE; DNA GLYCOSYLASES; DNA REPAIR; ESCHERICHIA COLI; LUCIFERASES; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MUSTARD GAS; MUTAGENESIS;

MAMMALIA;

EID: 34247626063     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2006.12.014     Document Type: Article

References (26)

1. Friedberg E.C., Walker G.C., Siede W., Wood R.D., Schultz R.A., and Ellenberger T. DNA Repair and Mutagenesis (2006), ASM Press, Washington, DC
2. Bonanno K., Wyrzykowski J., Chong W., Matijasevic Z., and Volkert M.R. Alkylation resistance of E. coli cells expressing different isoforms of human alkyladenine DNA glycosylase (hAAG). DNA Rep. 1 (2002) 507-517
3. Li Q., Wright S.E., Matijasevic Z., Chong W., Ludlum D.B., and Volkert M.R. The role of human alkyladenine glycosylase in cellular resistance to the chloroethylnitrosoureas. Carcinogenesis 24 (2003) 589-593
4. Engelward B.P., Dreslin A., Christensen J., Huszar D., Kurahara C., and Samson L. Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J. 15 (1996) 945-952
5. Allan J.M., Engelward B.P., Dreslin A.J., Wyatt M.D., Tomasz M., and Samson L.D. Mammalian 3-methyladenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents. Cancer Res. 58 (1998) 3965-3973
6. Matijasevic Z., Precopio M.L., Snyder J.E., and Ludlum D.B. Repair of sulfur mustard-induced DNA damage in mammalian cells measured by a host cell reactivation assay. Carcinogenesis 22 (2001) 661-664
7. Lawley P.D., Lethbridge J.H., Edwards P.A., and Shooter K.V. Inactivation of bacteriophage T7 by mono- and difunctional sulphur mustards in relation to cross-linking and depurination of bacteriophage DNA. J. Mol. Biol. 39 (1969) 181-198
8. Ludlum D.B., and Papirmeister B. DNA modification by sulfur mustards and nitrosoureas and repair of these lesions. Basic Life Sci. 38 (1986) 119-125
9. Roth R.B., and Samson L.D. 3-Methyladenine DNA glycosylase-deficient Aag null mice display unexpected bone marrow alkylation resistance. Cancer Res. 62 (2002) 656-660
10. Hofseth L.J., Khan M.A., Ambrose M., Nikolayeva O., Xu-Welliver M., Kartalou M., Hussain S.P., Roth R.B., Zhou X., Mechanic L.E., Zurer I., Rotter V., Samson L.D., and Harris C.C. The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J. Clin. Invest. 112 (2003) 1887-1894
11. Sobol R.W., Kartalou M., Almeida K.H., Joyce D.F., Engelward B.P., Horton J.K., Prasad R., Samson L.D., and Wilson S.H. Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses. J. Biol. Chem. 278 (2003) 39951-39959
12. Volkert M.R., and Nguyen D.C. Induction of specific Escherichia coli genes by sublethal treatments with alkylating agents. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 4110-4114
13. Elder R.H., Jansen J.G., Weeks R.J., Willington M.A., Deans B., Watson A.J., Mynett K.J., Bailey J.A., Cooper D.P., Rafferty J.A., Heeran M.C., Wijnhoven S.W., van Zeeland A.A., and Margison G.P. Alkylpurine-DNA-N-glycosylase knockout mice show increased susceptibility to induction of mutations by methyl methanesulfonate. Mol. Cell. Biol. 18 (1998) 5828-5837
14. McMahon A.P., and Bradley A. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62 (1990) 1073-1085
15. Freshney R.I. Culture of animal cells. A Manual of Basic Technique (1987), John Wiley and Sons, Inc., New York
16. Volkert M.R. Adaptive response of Escherichia coli to alkylation damage. Environ. Mol. Mutagen. 11 (1988) 241-255
17. Lindahl T., Sedgwick B., Sekiguchi M., and Nakabeppu Y. Regulation and expression of the adaptive response to alkylating agents. Annu. Rev. Biochem. 57 (1988) 133-157
18. Matijasevic Z., Snyder J.E., and Ludlum D.B. Hypothermia causes a reversible, p53-mediated cell cycle arrest in cultured fibroblasts. Oncol. Res. 10 (1998) 605-610
19. Matijasevic Z. Selective protection of non-cancer cells by hypothermia. Anticancer Res. 22 (2002) 3267-3272
20. 6-methylguanine and methylphosphotriester methyltransferase gene using a functional DNA repair assay. Nucl. Acids Res. 13 (1985) 1939-1952
21. Lau A.Y., Wyatt M.D., Glassner B.J., Samson L.D., and Ellenberger T. Molecular basis for discriminating between normal and damaged bases by the human alkyladenine glycosylase, AAG. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 13573-13578
22. Hollis T., Ichikawa Y., and Ellenberger T. DNA bending and a flip-out mechanism for base excision by the helix-hairpin-helix DNA glycosylase, Escherichia coli AlkA. EMBO J. 19 (2000) 758-766
23. 6-ethenoadenine repair by interacting with the human 3-methyladenine DNA glycosylase. Biochemistry 39 (2000) 8032-8038
24. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 5368-5372
25. 6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines. Clin. Cancer Res. 11 (2005) 2747-2755
26. Madhusudan S., and Middleton M.R. The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer. Cancer Treat. Rev. 31 (2005) 603-617